The impact of human papillomavirus (HPV) types 6, 11 in women with genital warts

被引:0
|
作者
Mahin Jamshidi
Mohammad Shekari
Abdol Azim Nejatizadeh
Keyanoush Malekzadeh
Mahnaz Baghershiroodi
Parivash Davudian
Farzaneh Dehghan
Froogh Jamshidi
机构
[1] Hormozgan University of Medical Sciences,Research Center for Molecular Medicine
[2] Hormozgan University of Medical Sciences,Infections Research Center
[3] Dermatology Private Clinic,undefined
来源
关键词
Human papillomavirus; Genital warts; PCR; Typing;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1261 / 1267
页数:6
相关论文
共 50 条
  • [1] The impact of human papillomavirus (HPV) types 6, 11 in women with genital warts
    Jamshidi, Mahin
    Shekari, Mohammad
    Nejatizadeh, Abdol Azim
    Malekzadeh, Keyanoush
    Baghershiroodi, Mahnaz
    Davudian, Parivash
    Dehghan, Farzaneh
    Jamshidi, Froogh
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2012, 286 (05) : 1261 - 1267
  • [2] Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 VaccineFor the Prevention of Genital Warts in Males
    Karly P. Garnock-Jones
    Anna R. Giuliano
    Drugs, 2011, 71 : 591 - 602
  • [3] Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine For the Prevention of Genital Warts in Males
    Garnock-Jones, Karly P.
    Giuliano, Anna R.
    DRUGS, 2011, 71 (05) : 591 - 602
  • [4] Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine for the Prevention of Genital Warts in Males
    Garnock-Jones, Karly P.
    Giuliano, Anna R.
    DRUGS IN R&D, 2012, 12 (04) : 235 - 238
  • [5] Quadrivalent human papillomavirus (HPV) types 6, 11, 16, 18 vaccine for the prevention of genital warts in males: Profile report
    Garnock-Jones K.P.
    Giuliano A.R.
    Drugs in R&D, 2012, 12 (4) : 235 - 238
  • [6] Detection of human papillomavirus types 6 and 11 in pubic and perianal hair from patients with genital warts
    Boxman, ILA
    Hogewoning, A
    Mulder, LHC
    Bavinck, JNB
    ter Schegget, J
    JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (07) : 2270 - 2273
  • [7] The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts
    Silverberg, MJ
    Ahdieh, L
    Muñoz, A
    Anastos, K
    Burk, RD
    Cu-Uvin, S
    Duerr, A
    Greenblatt, RM
    Klein, RS
    Massad, S
    Minkoff, H
    Muderspach, L
    Palefsky, J
    Piessens, E
    Schuman, P
    Watts, H
    Shah, KV
    SEXUALLY TRANSMITTED DISEASES, 2002, 29 (08) : 427 - 435
  • [8] Spotlight on Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®) in the Prevention of Premalignant Genital Lesions, Genital Cancer, and Genital Warts in Women
    Paul L. McCormack
    Elmar A. Joura
    BioDrugs, 2011, 25 : 339 - 343
  • [9] Spotlight on Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®) in the Prevention of Premalignant Genital Lesions, Genital Cancer, and Genital Warts in Women
    McCormack, Paul L.
    Joura, Elmar A.
    BIODRUGS, 2011, 25 (05) : 339 - 343
  • [10] Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
    Munoz, Nubia
    Kjaer, Susanne K.
    Sigurdsson, Kristjan
    Iversen, Ole-Erik
    Hernandez-Avila, Mauricio
    Wheeler, Cosette M.
    Perez, Gonzalo
    Brown, Darron R.
    Koutsky, Laura A.
    Tay, Eng Hseon
    Garcia, Patricia J.
    Ault, Kevin A.
    Garland, Suzanne M.
    Leodolter, Sepp
    Olsson, Sven-Eric
    Tang, Grace W. K.
    Ferris, Daron G.
    Paavonen, Jorma
    Steben, Marc
    Bosch, F. Xavier
    Dillner, Joakim
    Huh, Warner K.
    Joura, Elmar A.
    Kurman, Robert J.
    Majewski, Slawomir
    Myers, Evan R.
    Villa, Luisa L.
    Taddeo, Frank J.
    Roberts, Christine
    Tadesse, Amha
    Bryan, Janine T.
    Lupinacci, Lisa C.
    Giacoletti, Katherine E. D.
    Sings, Heather L.
    James, Margaret K.
    Hesley, Teresa M.
    Barr, Eliav
    Haupt, Richard M.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (05): : 325 - 339